John Capodanno

President, Financial Communications & Investor Relations


John Capodanno has over 20 years of corporate communications experience across a broad range of healthcare and life sciences companies, including large cap multinational pharmaceutical companies, small and mid-size biotech and medical device companies as well as large health insurers and regional hospital systems. Providing communications strategy and counsel to CEOs, CFOs, and heads of Communications, Marketing and HR has been a cornerstone of his career. His extensive experience includes advising companies on communicating business strategy, driving valuation, and managing and mitigating issues to provide them with the freedom to operate.

John has also built and grown teams that can collaborate and thrive in highly competitive environments; prior to joining W2O he led the Healthcare & Life Sciences sector for the Americas at FTI Consulting, overseeing a team that grew to include Corporate Communications, Financial Communications, Public Affairs, Employee Engagement and Change Management, Crisis, Transactions and Design and Digital. He was also the General Manager for the firm’s New York office, focusing on promoting a positive and engaged culture through targeted training, and cross-practice and cross-geography initiatives.

John has a long track record of leading and building programs for some of the world’s largest pharmaceutical and healthcare companies. His experience includes leading an award-winning program for one of the largest healthcare mergers of 2018; serving as an expert on behalf of a medical device company as claimant and counter-responder in litigation around the role of public relations and best practices for clinical trials; and, conceptualizing and implementing communications efforts for the Foundation of a Fortune 50 company, which won a top award from GBCHealth in 2016.

John started his career at one of the first-ever biotech focused communications firms, Noonan/Russo.